Images List Premium Download Classic

Cancer

Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods of diagnosing and treating cancer
UniversitÉ Paul Sabatier Toulouse Iii
August 17, 2017 - N°20170234881

The present invention relates to methods for the diagnosis and the treatment of cancer, in particular breast cancer. In particular, the present invention relates to a method of diagnosing cancer in a subject comprising the steps of i) determining the expression level of 11βhsd1 and/or 11βhsd2 in a sample obtained from the subject, ii) comparing ...
Compositions for detecting cancer cells on a cellular surface
Isi Life Sciences, Inc.
August 17, 2017 - N°20170234878

Disclosed are compositions and methods for assessing the presence of tumor cells amongst normal cells.
Methods and compositions for prognostic and/or diagnostic subtyping of pancreatic cancer
The University Of North Carolina At Chapel Hill
August 17, 2017 - N°20170233827

Methods for generating a prognostic and/or subtype signature for a subject with pancreatic ductal adenocarcinoma (pdac) are provided. In some embodiments, the methods include determining expression levels for one or more genes listed in tables 2-5, 9, 10, or 11, and/or the de-s and/or de-t subset of genes in pdac cells obtained from the subject, wherein the determining provides a ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Systems and methods of detecting solid tumor cancer
Adrastia Biotech Corporation
August 17, 2017 - N°20170233824

Provided herein are methods and kits for the detection of solid tumor cancers by measuring expression levels of at least one biomarker of solid tumor microenvironment potential or solid state tumor mass potential.
Microrna biomarker for the diagnosis of gastric cancer
National University Hospital (singapore) Pte Ltd
August 17, 2017 - N°20170233822

Disclosed are methods of determining the likelihood of a subject having or developing a gastric cancer. The methods comprise measuring the expression level of at least one mirna having at least 90% sequence identity with an mirna as described herein in a non-cellular biofluid sample obtained from the subject, wherein differential expression of mirna expression in the sample obtained from the ...
Methods for detecting cpg methylation and for diagnosing cancer
Epigenomics Ag
August 17, 2017 - N°20170233820

The present invention relates to the field of pharmacogenomics and in particular to detecting the presence or absence of hypermethylated dna. The detection of cpg methylation in marker dna is useful for the diagnosis of cancers and the invention provides improved methods for this purpose. These improved methods allow in particular for a more sensitive detection of methylated marker dna ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Dna aptamers against cancer and uses thereof in delivery of therapy and diagnosis of cancer
The University Of North Carolina At Charlotte
August 17, 2017 - N°20170233739

Disclosed herein are unique single stranded dna oligonucleotide products identified as binding with high affinity and specificity to ovarian tumor cells that may be used in the delivery of therapy to and diagnosis of ovarian cancer.
Genetic indicator and control system and method utilizing split cas9/crispr domains for transcriptional control ...
Tsinghua University
August 17, 2017 - N°20170233703

While genetic engineering has undergone rapid advancement with the discovery of crispr/cas9, there is room for improvement for genetic circuit control, precision (reducing circuit ‘leakiness’) and delivery into living systems. The claimed invention offers programmable and precise regulation of dcas9 functions in response to multiple molecular signals by using synthetic gene circuits, greatly expanding applications. Moreover, using ...
Antibodies specific for mmp9
Merck Patent Gmbh
August 17, 2017 - N°20170233495

The present invention relates to new proteins that bind to mmp9 and comprise at least one fragment of a heavy chain variable region and/or at least one fragment of a light chain variable region of an antibody. In particular, the mmp9 binding proteins according to the invention are able to neutralize mmp9 activity and are useful in the prevention ...
Dosage and administration of combination therapies comprising istiratumab, uses and methods of treatment
Merrimack Pharmaceuticals, Inc.
August 17, 2017 - N°20170233491

Disclosed herein are methods of treating pancreatic cancer in a human patient by co-administering istiratumab in combination with gemcitabine and nab-paclitaxel, and dosage regimens for the same.
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
The Regents Of The University Of California
August 17, 2017 - N°20170233488

This invention provides a method that allows selection of antibodies against cells (e. G., tumor cells) in situ using laser capture microdissection. By restricting antibody selection to binders of internalizing epitopes, a panel of phage antibodies was generated that targets clinically represented prostate cancer antigens.
Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
National Research Council Of Canada
August 17, 2017 - N°20170233487

Novel antibodies and antigen binding fragments that specifically bind to clusterin are described. In some embodiments, the antibodies block the biological activity of clusterin and are useful in composition in certain cancers, more particularly in cancers, such as endometrial carcinoma, breast carcinoma, hepatocellular carcinoma, prostate carcinoma, a renal cell carcinoma, ovarian carcinoma, pancreatic carcinoma, and colorectal carcinoma. The invention also ...
Bcma antibodies and use of same to treat cancer and immunological disorders
Seattle Genetics, Inc.
August 17, 2017 - N°20170233484

The invention provides humanized antibodies that specifically bind to bcma. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting bcma.
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Prophylaxis of colorectal and gastrointestinal cancer
Centre National De La Recherche Scientifique (cnrs)
August 17, 2017 - N°20170233469

The present disclosure provides methods and compositions useful for preventing gastrointestinal and/or colorectal cancer in animals, including humans, having pre-cancerous adenomatous polyps. The present disclosure provides compositions comprising anti-pg antibodies suitable for use in the methods of the disclosure. The present disclosure also provides methods and compositions useful for monitoring the efficacy of anti-pg treatment in subjects with pre-cancerous ...
Antibody against secreted n-terminal peptide of gpc3 present in blood or c-terminal peptide of gpc3
Chugai Seiyaku Kabushiki Kaisha
August 17, 2017 - N°20170233462

Disclosed is an antibody against a secreted form of gpc3 capable of detecting a secreted form of glypican 3 (gpc3) in a test sample. It is possible to determine whether a subject suffers from cancer, in particular hepatoma. Also disclosed is an antibody against gpc as well as a cell disrupting agent and an anti-cancer agent comprising the same, which can ...
Chimeric antigen receptors specific to avb6 integrin and methods of use thereof to treat cancer
Immusoft Corporation
August 17, 2017 - N°20170233452

Disclosed are chimeric antigen receptors (car) specific to αvβ6 integrin which is uniquely expressed in a wide variety of cancers. Also disclosed are vectors to express the car and methods to use the car to treat patients suffering from cancer. The instant disclosure provides a car comprising a binding domain specific to αv...
Compositions and methods comprising osmium for the treatment of cancers
Massachusetts Institute Of Technology
August 17, 2017 - N°20170233422

Compositions and methods comprising osmium are provided. In some embodiments, the osmium compounds comprise a bidentate ligand. In some embodiments, the osmium compounds are used in method for treating cancer.
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as ...
Eli Lilly And Company
August 17, 2017 - N°20170233378

1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as aicarft inhibitors.
Cancer therapeutics
University Of Virginia Patent Foundation
August 17, 2017 - N°20170233375

This invention relates to compounds that bind to wild-type cbfβ and inhibit cbfβ binding to runx proteins. The potent compounds of the invention inhibit this protein-protein interaction at low micromolar concentrations, using allosteric mechanism to achieve inhibition, displace wild-type cbfβ from runx1 in cells, change occupancy of runx1 on target genes, and alter gene ...
Separation of low-abundance cells from fluid using surface acoustic waves
The Penn State Research Foundation
August 17, 2017 - N°20170232439

An apparatus for sorting cells from a mixed population of cells using surface acoustic waves is described. Methods for separating cancer cells from a mixed population of cells are provided. Methods for separating cells or particles having different size, density and/or compressibility properties are also provided.
Cancer detection and treatment apparatus
Procept Biorobotics Corporation
August 17, 2017 - N°20170232273

A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured to expand from a narrow profile for insertion to a wide profile to engage and treat tissue remaining after resection. The expandable support can be sized to fit within a volume of removed ...
Loading